(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine, 95.0%, 100g

2,4-Dichloro-5-methoxypyrimidine>98.0%(GC)25g

TENATOPRAZOLE, 95%, 50mg

7-Bromobenzo[c][1,2,5]thiadiazole-4-carbaldehyde, 97.0%, 1g

tert-Butyl 4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 95.0%, 1g

Ester NHS de l’acide 6-azidohexanoïque 500 mg

Fil de cuivre recuit 99,998% 1,0 mm diamètre 1 m

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-cyclohexylpropanoic acid, 98%, 25g

Objectif corrigé à l'infini Plan Fluarex PLFi 100x/1.30 IOS. Distance de travail 0,13 mm

(3S)-8-fLuoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1h,3h)-quinazolinedione, 98%, 1g

((4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(diphenylmethanol), 97%, 100g

(E)-2-(4-methylphenyl)ethylenesulfonyl chloride, 95.0%, 500mg

tert-Butyl N-methyl-N-(pyrrolidin-3-yl)carbamate hydrochloride, 98+%, 10g